Company Overview
About Frontier Medicines
Frontier Medicines is a South San Francisco-based biopharmaceutical company founded in 2018 by Ulf Bhatt and Jonathan Ogg, with scientific founding involvement from leading chemoproteomics researchers. The company's core focus is developing precision medicines against proteins that have historically been considered "undruggable" — disease-causing targets where conventional drug discovery approaches have failed due to the protein's structure, chemistry, or biology. Frontier addresses this challenge through two proprietary technology platforms: the Frontier platform (chemoproteomics-based covalent chemistry for small molecule drug discovery) and the AutoTAC platform (targeted protein degradation using autophagy pathways).
Business Model & Competitive Advantage
Frontier's chemoproteomics approach uses mass spectrometry-based proteomics to systematically profile reactive cysteines and other functional residues across thousands of proteins simultaneously — identifying novel binding pockets on target proteins that can be engaged by covalent small molecules. This enables the company to design drugs that bind irreversibly to previously inaccessible sites on oncoproteins, opening up targets like mutant KRAS (a driver in ~30% of all cancers), STAT3, and others that have resisted drug discovery efforts for decades. The AutoTAC platform extends this by designing molecules that recruit autophagy machinery to selectively degrade target proteins — a targeted protein degradation approach complementary to the more widely known PROTAC technology.
Competitive Landscape 2025–2026
Frontier Medicines raised over $350M in total funding, including a $257M Series C in 2022 led by Dragoneer Investment Group, with participation from Foresite Capital, GV (Google Ventures), and others. The company's clinical programs span multiple oncology indications targeting KRAS and other precision oncology drivers. Frontier competes in the precision oncology drug discovery space with companies like Revolution Medicines, Relay Therapeutics, and Recursion Pharmaceuticals, as well as Big Pharma oncology R&D divisions pursuing similar undruggable targets.
Key Differentiators
Emerging Innovator
Frontier Medicines is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Similar Brands
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
Cradle
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, acti
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Compare Frontier Medicines with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Frontier Medicines? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Frontier Medicines Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Frontier Medicines vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →